Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viswanathan Mohan

Showing results (761-770 of 775) with videos related to

Pageof 78
Sort By:
The Lancet. Diabetes & Endocrinology|September 2, 2018
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological studyClara K Chow, Chinthanie Ramasundarahettige, Weihong Hu, et al.
The Lancet. Global Health|February 14, 2018
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational studyAdrianna Murphy, Benjamin Palafox, Owen O'Donnell, et al.
BMJ Global Health|March 6, 2020
The household economic burden of non-communicable diseases in 18 countriesAdrianna Murphy, Benjamin Palafox, Marjan Walli-Attaei, et al.
The Lancet. Global Health|April 28, 2019
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) studyAnnika Rosengren, Andrew Smyth, Sumathy Rangarajan, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
An ancestry-enriched HNF4A variant and GP2 reveal distinct mechanisms of type 2 diabetes in exome-wide study of 13,674 cases and 41,024 controlsSam Hodgson, Vi Bui, Siqi Hu, et al.
International Journal for Equity in Health|December 10, 2016
Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countriesBenjamin Palafox, Martin McKee, Dina Balabanova, et al.
The Lancet Regional Health. Southeast Asia|April 6, 2026
A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver StudyAshish Kumar, Jayant K Panda, Prabhat Agrawal, et al.
Diabetes|January 10, 2013
Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from IndiaRicha Saxena, Danish Saleheen, Latonya F Been, et al.
Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.
Pageof 78

Showing results (761-770 of 775) with videos related to

Sort By:
Pageof 78
The Lancet. Diabetes & Endocrinology|September 2, 2018
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological studyClara K Chow, Chinthanie Ramasundarahettige, Weihong Hu, et al.
The Lancet. Global Health|February 14, 2018
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational studyAdrianna Murphy, Benjamin Palafox, Owen O'Donnell, et al.
BMJ Global Health|March 6, 2020
The household economic burden of non-communicable diseases in 18 countriesAdrianna Murphy, Benjamin Palafox, Marjan Walli-Attaei, et al.
The Lancet. Global Health|April 28, 2019
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) studyAnnika Rosengren, Andrew Smyth, Sumathy Rangarajan, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
An ancestry-enriched HNF4A variant and GP2 reveal distinct mechanisms of type 2 diabetes in exome-wide study of 13,674 cases and 41,024 controlsSam Hodgson, Vi Bui, Siqi Hu, et al.
International Journal for Equity in Health|December 10, 2016
Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countriesBenjamin Palafox, Martin McKee, Dina Balabanova, et al.
The Lancet Regional Health. Southeast Asia|April 6, 2026
A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver StudyAshish Kumar, Jayant K Panda, Prabhat Agrawal, et al.
Diabetes|January 10, 2013
Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from IndiaRicha Saxena, Danish Saleheen, Latonya F Been, et al.
Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.
Pageof 78